• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Individual and network factors associated with HCV treatment uptake among people who inject drugs.与注射毒品者接受丙型肝炎病毒治疗相关的个体因素和网络因素。
Int J Drug Policy. 2020 Apr;78:102714. doi: 10.1016/j.drugpo.2020.102714. Epub 2020 Mar 2.
2
Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.直接和间接的社会及空间关系在注射吸毒人群中 HIV 和 HCV 传播中的作用:印度新德里基于社区的横断面网络分析
Elife. 2021 Aug 3;10:e69174. doi: 10.7554/eLife.69174.
3
Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era.口服直接抗病毒药物时代注射吸毒者的丙型肝炎治疗情况
Liver Int. 2020 Oct;40(10):2407-2416. doi: 10.1111/liv.14634.
4
Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.印度东北部注射毒品女性中艾滋病毒和丙型肝炎感染的流行病学:一项应答者驱动抽样研究。
Addiction. 2017 Aug;112(8):1480-1487. doi: 10.1111/add.13821. Epub 2017 Apr 18.
5
Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.印度采用应答者驱动抽样法识别注射吸毒的艾滋病毒和丙型肝炎病毒感染者及男男性行为者:一项基于社区的横断面分析。
PLoS Med. 2017 Nov 28;14(11):e1002460. doi: 10.1371/journal.pmed.1002460. eCollection 2017 Nov.
6
Drug use stigma and its association with active hepatitis C virus infection and injection drug use behaviors among community-based people who inject drugs in India.印度基于社区的注射吸毒人群中药物使用污名与丙型肝炎病毒感染和注射吸毒行为的关联。
Int J Drug Policy. 2021 Oct;96:103354. doi: 10.1016/j.drugpo.2021.103354. Epub 2021 Jul 8.
7
Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.调查英格兰、威尔士和北爱尔兰注射吸毒者中与丙型肝炎病毒检测相关的社会人口学和行为因素:一项定量横断面分析。
Int J Drug Policy. 2022 Nov;109:103821. doi: 10.1016/j.drugpo.2022.103821. Epub 2022 Aug 20.
8
Perceptions of network based recruitment for hepatitis C testing and treatment among persons who inject drugs: a qualitative exploration.基于网络的丙型肝炎检测和治疗招募在注射毒品者中的认知:定性探讨。
Int J Drug Policy. 2021 Feb;88:103019. doi: 10.1016/j.drugpo.2020.103019. Epub 2020 Nov 4.
9
Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.泰国清迈府危险注射行为与丙型肝炎病毒认知:一项针对注射吸毒者的应答驱动抽样研究
BMC Public Health. 2020 Sep 24;20(1):1450. doi: 10.1186/s12889-020-09549-w.
10
Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.年龄和性别特异性丙型肝炎连续护理以及华盛顿州西雅图注射吸毒者直接作用抗病毒治疗的预测因素。
Drug Alcohol Depend. 2021 Mar 1;220:108525. doi: 10.1016/j.drugalcdep.2021.108525. Epub 2021 Jan 11.

引用本文的文献

1
Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study.波士顿都会区注射吸毒者的监禁史与艾滋病毒检测:一项汇总横断面研究。
Res Sq. 2024 Dec 17:rs.3.rs-5367945. doi: 10.21203/rs.3.rs-5367945/v1.
2
Infectious Diseases Among People Experiencing Homelessness: A Systematic Review of the Literature in the United States and Canada, 2003-2022.美国和加拿大 2003-2022 年流浪人群中传染病研究:文献系统性回顾
Public Health Rep. 2024 Sep-Oct;139(5):532-548. doi: 10.1177/00333549241228525. Epub 2024 Feb 20.
3
CHIME - A tailored HCV microelimination project in Viennese people who inject drugs at drug centralized substitution centers.CHIME——一项针对在毒品集中替代中心注射毒品的维也纳人的定制丙型肝炎微消除项目。
J Virus Erad. 2023 Jul 27;9(3):100338. doi: 10.1016/j.jve.2023.100338. eCollection 2023 Sep.
4
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in Iran.伊朗注射毒品人群中的丙型肝炎病毒流行率、决定因素和关怀传递。
Drug Alcohol Depend. 2023 Feb 1;243:109751. doi: 10.1016/j.drugalcdep.2022.109751. Epub 2023 Jan 2.
5
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs.实施药师、医生和患者导航员合作护理模式(PPP-CCM)以治疗注射吸毒者丙型肝炎的障碍和促进因素。
Int J Drug Policy. 2023 Jan;111:103924. doi: 10.1016/j.drugpo.2022.103924. Epub 2022 Dec 13.
6
Social Networks, Stigma, and Hepatitis C Care Among Women Who Inject Drugs: Findings from A Community Recruited Sample.注射毒品女性中的社交网络、污名与丙型肝炎护理:来自社区招募样本的研究结果
J Psychoactive Drugs. 2023 Sep-Oct;55(4):464-470. doi: 10.1080/02791072.2022.2129886. Epub 2022 Dec 1.
7
Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.定性研究:美国华盛顿州西雅图市感染丙型肝炎的注射吸毒者对 HIV 暴露前预防的认知
Harm Reduct J. 2022 Nov 1;19(1):121. doi: 10.1186/s12954-022-00706-5.
8
Factors Associated with Sustained Virologic Response to Hepatitis C Treatment in a Homeless-Experienced Cohort in Boston, 2014-2020.2014-2020 年波士顿无家可归者队列中与丙型肝炎治疗持续病毒学应答相关的因素。
J Gen Intern Med. 2023 Mar;38(4):865-872. doi: 10.1007/s11606-022-07778-w. Epub 2022 Sep 20.
9
Reliving it All Over Again: Uncanny Temporalities of Injection Drug Use and Hepatitis C Diagnosis in Southwest Virginia, USA.旧事重演:美国弗吉尼亚州西南部注射吸毒和丙型肝炎诊断的不可思议的时间性。
Med Anthropol. 2023 Jan 2;42(1):21-34. doi: 10.1080/01459740.2022.2110090. Epub 2022 Aug 9.
10
Future destinations and social inclusion scoping review: how people cured of hepatitis C (HCV) using direct- acting antiviral drugs progress in a new HCV-free world.未来的目的地和社会包容范围审查:使用直接作用抗病毒药物治愈丙型肝炎(HCV)的人如何在一个新的无 HCV 世界中取得进展。
Subst Abuse Treat Prev Policy. 2022 Jun 8;17(1):45. doi: 10.1186/s13011-022-00475-1.

本文引用的文献

1
Network-based recruitment of people who inject drugs for hepatitis C testing and linkage to care.基于网络招募注射毒品者进行丙型肝炎检测并建立联系以获得治疗。
J Viral Hepat. 2020 Jul;27(7):663-670. doi: 10.1111/jvh.13274. Epub 2020 Mar 2.
2
Making sense of 'side effects': Counterpublic health in the era of direct-acting antivirals.解读“副作用”:直接作用抗病毒药物时代的反公共卫生。
Int J Drug Policy. 2019 Oct;72:77-83. doi: 10.1016/j.drugpo.2019.06.002. Epub 2019 Jun 17.
3
Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients.静脉注射吸毒是 HIV 感染患者接受丙型肝炎治疗的主要障碍。
HIV Med. 2019 Jul;20(6):359-367. doi: 10.1111/hiv.12715. Epub 2019 Apr 22.
4
Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.在加拿大环境下,注射吸毒人群中直接作用抗病毒疗法治疗丙型肝炎的接受率存在差异。
Liver Int. 2019 Aug;39(8):1400-1407. doi: 10.1111/liv.14043. Epub 2019 Feb 24.
5
HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014-2015.2014-2015 年 HIV 护理患者中的 HCV 筛查和治疗接受情况。
J Acquir Immune Defic Syndr. 2019 Apr 15;80(5):559-567. doi: 10.1097/QAI.0000000000001949.
6
Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle.西雅图注射吸毒者丙型肝炎连续护理以及卫生保健和减少伤害服务的利用情况。
Drug Alcohol Depend. 2019 Feb 1;195:114-120. doi: 10.1016/j.drugalcdep.2018.11.026. Epub 2018 Dec 26.
7
Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system.在全民医保体系中,注射吸毒者对直接作用抗病毒疗法治疗丙型肝炎病毒的接受程度。
Drug Alcohol Rev. 2019 Mar;38(3):264-269. doi: 10.1111/dar.12883. Epub 2018 Dec 12.
8
Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.阻碍和促进丙型肝炎(HCV)筛查和治疗的因素——囚犯视角的描述。
Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.
9
Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.保险人群中丙型肝炎病毒感染直接作用抗病毒药物起始治疗的差异。
Public Health Rep. 2018 Jul/Aug;133(4):452-460. doi: 10.1177/0033354918772059. Epub 2018 May 11.
10
Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease.直接作用抗病毒药物持续病毒学应答:对无晚期肝病患者死亡率的影响。
Hepatology. 2018 Sep;68(3):827-838. doi: 10.1002/hep.29811. Epub 2018 May 14.

与注射毒品者接受丙型肝炎病毒治疗相关的个体因素和网络因素。

Individual and network factors associated with HCV treatment uptake among people who inject drugs.

作者信息

Falade-Nwulia Oluwaseun, Sacamano Paul, McCormick Sean D, Yang Cui, Kirk Greg, Thomas David, Sulkowski Mark, Latkin Carl, Mehta Shruti H

机构信息

Johns Hopkins University School of Medicine, 725 N. Wolfe Street, Suite 215, Baltimore, MD 21205, USA.

Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Int J Drug Policy. 2020 Apr;78:102714. doi: 10.1016/j.drugpo.2020.102714. Epub 2020 Mar 2.

DOI:10.1016/j.drugpo.2020.102714
PMID:32135398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7367433/
Abstract

BACKGROUND

Hepatitis C virus (HCV) treatment uptake among people who inject drugs (PWID), a population with disproportionately high rates of HCV, remains low. Peers have been shown to positively impact a broad range of health outcomes for PWID. There is, however, limited data on the impact of PWID social network members on HCV treatment.

METHODS

HCV-infected PWID enrolled in an ongoing community-based cohort were recruited as "indexes" to complete an egocentric social network survey. The survey elicited from the index PWID a list of their network members and the index's perception of network member characteristics. Logistic regression analyses were conducted to compare individual and network factors associated with HCV treatment in the index PWID.

RESULTS

Among 540 HCV-infected PWID, the mean age was 55.7 years and the majority were black (87.2%) and male (69.8%). PWID reported a mean of 4.4 (standard deviation [SD] 3.2) network members, most of whom were relatives (mean 2.2 [SD 1.5]). In multivariable analysis, increasing index age and HIV infection were positively associated with HCV treatment, while drug use and homelessness in the preceding 6 months were negatively associated with HCV treatment. From a network perspective, having at least one network member who regularly talked with the index about seeing their doctor for HIV care was associated with HCV treatment (Adjusted Odds Ratio [AOR] 2.7; 95% Confidence Interval (CI) [1.3, 5.6]). Conversely, PWID who had at least one network member who helped them understand their HCV care were less likely to have been HCV treated (AOR 0.2; CI [0.1, 0.6).

CONCLUSION

HCV treatment uptake in this group of PWID appeared to be positively influenced by discussions with network members living with HIV who were in care and negatively influenced by HCV information sharing within PWID networks. These findings underscore the influence of peers on health seeking behaviors of their network members and emphasizes the importance of well-informed peers.

摘要

背景

在注射吸毒者(PWID)中,丙型肝炎病毒(HCV)治疗的接受率仍然很低,而这一人群的HCV感染率高得不成比例。已有研究表明,同伴对PWID的广泛健康结果有积极影响。然而,关于PWID社交网络成员对HCV治疗影响的数据有限。

方法

招募参与一项正在进行的基于社区队列研究的HCV感染PWID作为“索引”,以完成一项自我中心社交网络调查。该调查从索引PWID那里获取其网络成员列表以及索引对网络成员特征的看法。进行逻辑回归分析,以比较与索引PWID中HCV治疗相关的个体因素和网络因素。

结果

在540名HCV感染的PWID中,平均年龄为55.7岁,大多数为黑人(87.2%)和男性(69.8%)。PWID报告的网络成员平均数量为4.4名(标准差[SD]为3.2),其中大多数是亲属(平均2.2名[SD 1.5])。在多变量分析中,索引年龄的增加和HIV感染与HCV治疗呈正相关,而前6个月的吸毒和无家可归与HCV治疗呈负相关。从网络角度来看,至少有一名网络成员经常与索引谈论看医生接受HIV治疗与HCV治疗相关(调整后的优势比[AOR]为2.7;95%置信区间[CI][1.3, 5.6])。相反,至少有一名网络成员帮助他们了解HCV护理的PWID接受HCV治疗的可能性较小(AOR为0.2;CI[0.1, 0.6])。

结论

这组PWID中的HCV治疗接受情况似乎受到与接受护理的HIV感染者网络成员讨论的积极影响,而受到PWID网络内HCV信息共享的消极影响。这些发现强调了同伴对其网络成员健康寻求行为的影响,并强调了信息充分的同伴的重要性。